Skip to content Skip to navigation

CCRM in the News 2020

A sampling of media coverage that profiles or mentions CCRM

Notch Therapeutics Appoints David Main as President and CEO to Advance the Company's Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics. Canadian Life Sciences Database, July 20, 2020. 

U of T spin-off Empirica Therapeutics acquired by U.S. firm. U of T News, July 15, 2020.

Innovation Economy Council: Advanced mfg booming in Ontario. Canadian Manufacturing, July 9, 2020.

Professor's startup acquired by U.S. firm. Brighter World (McMaster University), June 26, 2020.

Medicine by Design Launches Translation Talks. Medicine by Design website, June 16, 2020.

The New Wave of Innovation. Contract Pharma, June 4, 2020.

The Short Report. Research Money, May 20, 2020. 

Report: Startups Could Fuel The Recovery Of Canada's Economy. BetaKit, April 28, 2020.

Tech startups are the foundation of Canada's economic revival and will need stimulus to survive. The Globe and Mail, April 28, 2020. 

Master iPSC bank to be produced by CCRM and panCELLa. RegMedNet, April 23, 2020.  

panCELLa, CCRM collaborate to benefit academia and industry. Contract Pharma, April 21, 2020.

Avectas collaborates with CCRM on cell engineering tech. BioPharma Reporter, March 4, 2020.

Advancing Platelet-Based Therapeutics for PatientsGenetic Engineering & Biotechnology News, February 11, 2020

Reflections On An Unprecedented Decade In The Cell And Gene Therapy Field. Cell & Gene, February 4, 2020

Why stem cells could be the medical innovation of the century. World Economic Forum website. January 16, 2020

CCRM helping to solve the big problems in regenerative medicineGenetic Engineering & Biotechnology News, January 3, 2020